The Tricho-Hepato-Enteric (THE) syndrome is an autosomal recessive condition marked by early and intractable diarrhea, hair abnormalities and immune defects. Mutations in TTC37 which encodes the putative protein Thespin, have recently been associated with THE syndrome. In this paper, we extend the pattern of TTC37 mutations by the description of 11 novel mutations in 9 patients with a typical THE syndrome. The mutations were spread along the gene sequence, none of them being recurrent. Different types of mutation were observed: frameshift mutations, splice site altering mutations or missense mutations, most of them leading to the creation of a premature stop codon. Concurrently, we investigated the pattern of TTC37 expression in a panel of normal human tissues and showed that this gene is widely expressed, with high levels in vascular tissues, lymph node, pituitary, lung and intestine. In contrast, TTC37 is not expressed in the liver, an organ which is not consistently affected in THE syndrome. Lastly, we suggested a model for the putative structure of the unknown Thespin protein.
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Introduction
The Tricho-Hepato-Enteric syndrome (THE syndrome, OMIM n°222470) also known as Syndromic Diarrhea, is a rare and severe autosomal recessive condition which associates intractable diarrhea with facial dysmorphism, intrauterine growth retardation, immunodeficiency with low serum concentrations of immunoglobulins, and hair abnormalities characterized by woolly hair (Girault et al., 1994; Verloes et al., 1997) .
Parenteral nutrition is usually started in the first weeks of life and maintained all life long in most cases. The liver failure is inconstant and when present, it is observed initially or later on in life. In the past, the presence or absence of liver failure led one to describe 2 different syndromes but it is now admitted that the 2 entities represent 2 sides of the same disease (Fabre et al, 2007 , Goulet et al, 2008 . Death can occur early in life even though some patients can reach the third decade.
In the past few years, we collected samples for 12 patients from 11 families, all presenting a typical phenotype of THE syndrome. We first excluded several functional candidate genes (Fabre et al, 2009 ) and then performed a linkage analysis in order to unravel the genetic basis of this syndrome. In 2 of the 3 consanguineous families, homozygosity mapping identified a 5Mb region in 5q as a potential locus for the disease.
Very recently, Hartley et al described molecular defects causative for THE syndrome in TTC37 (NM_014639), a gene encoding for a putative protein named Thespin. Their study reported 9 mutations transmitted in a recessive pattern in 12 patients presenting this syndrome.
Since TTC37 maps in 5q, we assumed that this gene may be responsible for the disease in some of our patients and so performed systematic sequencing of genomic DNA samples. In this paper, we describe 11 novel TTC37 mutations in 9 patients out of 12 and provide clinical 
Material and methods:
Patients
Patients and family members were assessed under approved human subject protocols and all participants provided informed consent.
Molecular studies
DNA was isolated from blood via a standard manufacturer's protocol (QIAamp DNA blood minikit, QIAgen). To analyse the TTC37 gene, direct sequencing was performed, after PCR amplification of the 43 exons and intronic flanking sequences, on an ABI 3130XL (Applied Biosystems).
The TTC37 genomic sequence from GenBank accession numbers NM_014639 was used as reference sequence. Detailed protocols and primer sequences are available on request. Two non-mutated patients and one heterozygous were tested by CGH array using the commercial Agilent 2x400K SurePrint G3 Human CGH Microarray (Agilent Technologies) array with the overall median probe spacing of 5,3 kb. Total RNA from 3 patient samples was prepared from lymphoblastoid cells and reverse transcribed using M-MLV (Sygma). Normal expression pattern was investigated by qPCR on a panel of normal transcripts from various tissues (Rapid-Scan cDNA panel, OriGene) using a probe located on exon-intron junction 35-36 of TTC37 and compared to GAPDH expression in duplex reactions. qPCR were done in triplicates and 2 sets of experiments were performed.
Bioinformatics analysis
The topology of normal and mutated Thespin protein was analysed using the algorithms proposed at TMpred (http://www.ch.embnet.org/software/TMPRED_form.html), TOPPRED 
Results
Patients phenotype
The clinical features of the 12 patients are summarised in table 1. Detailed clinical data were previously published for 3 of them (Fabre et al, 2007 , Egritas et al 2010 . All the 12 patients presented the 3 major signs of THE syndrome i.e. dysmorphism, hair abnormalities and intractable diarrhea. Among the 12 patients, one died of septicemia at age 10, 2 have stopped parenteral nutrition and 1 never required it.
Identification and characterization of novel TTC37 mutations in THE patients
Screening for mutations of TTC37 coding sequence and intron-exon junctions of DNA samples from THE patients identified 10 novel non ambiguous mutations in homozygous or compound heterozygous condition, in 8 (out of 12) patients. In addition, one patient presented only a heterozygous missense mutation. The mutations were spread along the gene: 3 were nonsense or frameshift mutations in the coding sequence leading to premature stop codon, 5
were mutations affecting splice sites either by substitution or deletion and 3 were missense mutations. All the parents of mutated patients were investigated and carried a mutation in heterozygous condition. The location and predicted consequences of the mutations on protein expression or function are reported in table 2.
Two of the 3 patients without mutation and the one with a single heterozygous mutation were investigated by whole genome CGH array with 17 probes mapping in TTC37. No CNV of the TTC37 region or of other regions could be identified. 
Pattern of expression
Quantitative expression in normal tissues was assessed in a panel of 48 different tissues and revealed that TTC37 is widely expressed with the highest levels observed in vascular tissues, lymph node, pituitary, lung and intestine. Noticeably, we did not find any expression in the liver (figure 2).
Bioinformatics
In silico protein predictions were performed to propose a putative structure for Thespin and to evaluate the potential effect of TTC37 mutations identified in this study. The algorithm results are in accordance to predict that Thespin is mostly cytosolic and may contain 4 transmembrane domains (Figure 3) . With all algorithms used in this study, several tetratricopeptide repeats (TPR) domains are predicted and their number varies from 5 to 22.
Discussion
Mutations previously identified in THE syndrome are heterogeneous and include frameshift, nonsense and splice site mutations. Here, we describe further 11 different mutations that add heterogeneity to the molecular genetics of THE syndrome (figure 3). These 11 novel mutations, in addition to the 9 mutations previously described, indicate strongly that TTC37 is the main gene responsible for THE syndrome. There is no clear hot spot region for mutations mutations that are predicted to produce premature stop codon. At least, 2 of the 3 missense mutations might affect splicing as well, as they are located in the vicinity of splice sites. For one of the patients, a single missense mutation in heterozygous condition has been identified to date. As we exclude the presence of an intragenic deletion or duplication on the other allele, we assume that a non-identified intronic substitution producing an aberrant splicing is probably associated with the missense mutation.
The phenotypes of the 3 patients who did not carry any mutation in TTC37 have been carefully re-evaluated and were confirmed as being typical THE syndrome, suggesting strongly that at least one other gene may be implicated in this disease.
Multi-tissue transcript expression analysis showed wide expression of TTC37 mRNA with a high expression level in intestinal tissue but not in the liver, indicating that liver dysfunction observed in THE syndrome is probably secondary to another genetic cause or to long term parenteral nutrition. More surprising is the high level of expression observed in vein, arteria and lung as no abnormalities have been noticed in these tissues.
Up to date, the function of Thespin is unknown. We identified orthologs of human TTC37 using HomoloGene (www.ncbi.nlm.nih.gov/homologene) and found a nucleotide sequence conservation in canis (92%), bos (92%), rattus (83%), mus (82%), gallus (66%), danio (55%) and drosophila (27%) in favour of an essential role for Thespin.
Protein motifs and domains are predicted in Thespin by several algorithms such as TMpred, PSORT and TOPPRED. Four transmembrane domains located in the C-terminal half of the protein are predicted, the last one in the C-terminal part being predicted with a stronger score.
The putative protein also contains several tetratrico-peptide repeats (TPR) domains which are structural motifs consisting of 34 Amino acid residues and found in over 300 human proteins Beside the TPR domains, neither the gene nor its derived protein show any significant sequence similarity to other known human DNA or protein sequences. In the literature, mutations in other TPRs containing proteins have been described as causative in several neurological human diseases such as Leber congenital amaurosis (Sohocki et al, 2000) or CMT type 4C (Senderek et al, 2003) but no clear link can be made between these proteins and their putative function.
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